BOSTON– Instem, a global provider of software and services for the life sciences industry, has announced its acquisition of Strong Tower Solutions (STS), a Pennsylvania-based technology services firm specializing in the deployment of compliant Statistical Computing Environments (SCE) for clinical trials. The move enhances Instem’s capabilities in clinical development and strengthens its position as a leader in SCE solutions.
With nearly two decades of experience, Strong Tower Solutions has built a reputation for configuring, validating, and supporting highly regulated computing environments that help life sciences companies conduct clinical trials while maintaining compliance with regulatory requirements.
“This acquisition marks a significant step in our mission to accelerate and advance scientific discovery,” said Vik Krishnan, CEO of Instem. “By integrating STS’s expertise into our platform, we’re enabling faster, more effective decision-making and reducing risk across the clinical development process.”
The acquisition allows Instem to expand its SCE offerings to a broader client base, from small biotech firms to large pharmaceutical companies. By combining forces, the two companies aim to deliver more flexible, cloud-native SCE solutions tailored to each client’s specific needs, ensuring compliance while supporting innovation.
Stephen Baker, General Manager of Instem’s Clinical Division, emphasized the strategic importance of the move. “Instem is at the forefront of SCE modernization. Bringing STS into our ecosystem furthers our commitment to delivering open, cloud-based analysis and reporting systems. This acquisition complements our previous acquisition of d-wise and strengthens our leadership in the clinical computing space.”
John Norton, Director of Customer Success at Strong Tower Solutions, noted the benefits of the acquisition for existing and future clients. “Our mission has always been to deliver precisely configured and compliant environments. With Instem, our customers will gain access to a broader range of technologies and resources, helping them stay ahead of industry changes and regulatory shifts.”
Instem’s clinical segment continues to position itself as a thought leader in SCE innovation, providing integrated software, expert services, and guidance to life sciences clients navigating complex clinical trials. The addition of Strong Tower Solutions further supports Instem’s goal of simplifying and modernizing computing environments to accelerate compliant drug development.
